Clinical features of critically ill patients with shiga toxin-induced hemolytic uremic syndrome

Critical Care Medicine

Volumn 41, Issue 7, 2013, Pages 1702-1710

  Braune, Stephan A ^a   Wichmann, Dominic ^a   Von Heinz, Marie C ^a   Nierhaus, Axel ^a   Becker, Heinrich ^b   Meyer, Tobias N ^b   Meyer, Gerd P ^c   Müller Schulz, Matthias ^d   Fricke, Jens ^e   De Weerth, Andreas ^d   Hoepker, Wilhelm W ^a   Fiehler, Jens ^a   Magnus, Tim ^a   Gerloff, Christian ^a   Panzer, Ulf ^a   Stahl, Rolf A K ^a   Wegscheider, Karl ^a   Kluge, Stefan ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b ASKLEPIOS HOSPITAL BARMBEK   (Germany)

^c ASKLEPIOS KLINIK ALTONA   (Germany)

^d Marienkrankenhaus ^*  (Germany)

^e Asklepios Klinik Harburg   (Germany)

Author keywords

acute renal failure; crisis management; Escherichia coli O104; H4; hemolytic uremic syndrome; ICU; neurological symptoms; outbreak; plasma exchange; Shiga toxin associated hemolytic uremic syndrome

Indexed keywords

AZITHROMYCIN; BENZODIAZEPINE DERIVATIVE; CARBAPENEM DERIVATIVE; CORTICOSTEROID; ECULIZUMAB; ETIRACETAM; NORADRENALIN; PHENYTOIN; SHIGA TOXIN; VALPROIC ACID;

ABDOMINAL PAIN; ABDOMINAL SURGERY; ABDUCENS NERVE PARALYSIS; ACUTE KIDNEY FAILURE; ADULT; AGED; ANTIBIOTIC THERAPY; ANTICONVULSANT THERAPY; ANXIETY; APHASIA; APRAXIA; ARTICLE; ARTIFICIAL VENTILATION; BLOODY DIARRHEA; CATHETER INFECTION; CHOLANGITIS; CLINICAL FEATURE; COGNITIVE DEFECT; COLITIS; COMORBIDITY; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISORIENTATION; ELECTROENCEPHALOGRAPHY; EPIDEMIC; FEMALE; GLASGOW COMA SCALE; HEADACHE; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTESTINE HEMATOMA; INTESTINE NECROSIS; INTUBATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOCLONUS; NAUSEA; NEUROLOGIC DISEASE; NONINVASIVE VENTILATION; OBSERVATIONAL STUDY; PANCREATITIS; PERITONITIS; PLASMAPHERESIS; PNEUMONIA; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RESPIRATORY FAILURE; RESTLESSNESS; RETROSPECTIVE STUDY; SEIZURE; SEPSIS; SEPTIC SHOCK; SEROTYPE; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; TRACHEOSTOMY; TREATMENT DURATION; TREATMENT OUTCOME; ULCER; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CRITICAL ILLNESS; ESCHERICHIA COLI INFECTIONS; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; SEPSIS; SHIGA TOXIN; YOUNG ADULT;

EID: 84880571298     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31828a24a8     Document Type: Article

References (35)

1. Frank C, Werber D, Cramer JP, et al: Epidemic profile of Shiga-toxinproducing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 2011; 365:1771-1780
2. Robert Koch Institut: Abschließende Darstellung und Bewertung der epidemiologischen Erkenntnisse im EHEC O104:H4 [Final Epidemiological Report on the German O104:H4 EHEC Crisis]. Ausbruch, Deutschland, Robert Koch Institut, 2011. Available at: http://www.rki.de/DE/Content/InfAZ/E/EHEC/EHEC- Abschlussbericht. pdf?-blob=publicationFile. Accessed October 26, 2012
3. Wendel AM, Johnson DH, Sharapov U, et al: Multistate outbreak of Escherichia coli O157:H7 infection associated with consumption of packaged spinach, August-September 2006: The Wisconsin investigation. Clin Infect Dis 2009; 48:1079-1086
4. Rohde H, Qin J, Cui Y, et al: Open-source genomic analysis of Shiga-toxin-producing E. coli O104:H4. N Engl J Med 2011; 365: 718-724
5. Scheutz F, Nielsen EM, Frimodt-Møller J, et al: Characteristics of the enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011. Euro Surveill 2011; 16
6. Gasser C, Gautier E, Steck A, et al: Hemolytic-uremic syndrome: Bilateral necrosis of the renal cortex in acute acquired hemolytic anemia. Schweiz Med Wochenschr 1955; 85:905-909
7. Pennington H: Escherichia coli O157. Lancet 2010; 376:1428-1435
8. Buchholz U, Bernard H, Werber D, et al: German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med 2011; 365:1763-1770
9. Tarr PI, Gordon CA, Chandler WL: Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365:1073-1086
10. Singbartl K, Kellum JA: AKI in the ICU: Definition, epidemiology, risk stratification, and outcomes. Kidney Int 2012; 81:819-825
11. Schmid H, Schiffl H, Lederer SR: Acute kidney injury. Med Klin Intensivmed Notfmed 2012; 107:141-146
12. Magnus T, Röther J, Simova O, et al: The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak. Brain 2012; 135(Pt 6):1850-1859
13. Galle J. Therapeutische Apheresebehandlung bei EHEC assoziiertem HUS [Therapeutic Apheresis in EHEC Associated HUS]. Available at: http://www.dgfn.eu/aktuell/ehec-informationen/fuer-das-fachpublikum/ therapeutische-apheresebehandlung-bei-ehec-assoziiertemhus/. Accessed October 26, 2012
14. German EHEC-HUS Registry: The German 2011 epidemic of Shiga toxin-producing E. Coli - The nephrological view. Nephrol Dial Transplant 2011; 26:2723-2726
15. Mellmann A, Bielaszewska M, Köck R, et al: Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli. Emerging Infect Dis 2008; 14:1287-1290
16. Cordesmeyer S, Peitz U, Gödde N, et al: Colonic ischaemia as a severe Shiga toxin/verotoxin producing Escherichia coli O104:H4 complication in a patient without haemolytic uraemic syndrome, Germany, June 2011. Euro Surveill 2011; 16. pii:19895
17. de Buys Roessingh AS, de Lagausie P, Baudoin V, et al: Gastrointestinal complications of post-diarrheal hemolytic uremic syndrome. Eur J Pediatr Surg 2007; 17:328-334
18. Garg AX, Suri RS, Barrowman N, et al: Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: A systematic review, meta-analysis, and meta-regression. JAMA 2003; 290:1360-1370
19. Pene F, Vigneau C, Auburtin M, et al: Outcome of severe adult thrombotic microangiopathies in the intensive care unit. Intensive Care Med 2005; 31:71-78
20. Dundas S, Todd WT, Stewart AI, et al: The central Scotland Escherichia coli O157:H7 outbreak: Risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis 2001; 33:923-931
21. Gould LH, Demma L, Jones TF, et al: Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. Clin Infect Dis 2009; 49:1480-1485
22. Kumar A, Zarychanski R, Pinto R, et al: Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009; 302:1872-1879
23. Harendza S: "HUS diary" of a German nephrologist during the current EHEC outbreak in Europe. Kidney Int 2011; 80:687-689
24. Hauri A, Gotsch U, Strotmann I, et al: Secondary transmissions during the outbreak of Shiga toxin-producing Escherichia coli O104 in Hesse, Germany, 2011. Euro Surveill 2011; 16. pii:19937
25. Trachtman H, Austin C, Lewinski M, et al: Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol 2012; 8:658-669
26. Dundas S, Murphy J, Soutar RL, et al: Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak. Lancet 1999; 354:1327-1330
27. Greinacher A, Friesecke S, Abel P, et al: Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: A prospective trial. Lancet 2011; 378:1166-1173
28. Nürnberger J, Philipp T, Witzke O, et al: Eculizumab for atypical hemolytic- uremic syndrome. N Engl J Med 2009; 360:542-544
29. Orth D, Khan AB, Naim A, et al: Shiga toxin activates complement and binds factor H: Evidence for an active role of complement in hemolytic uremic syndrome. J Immunol 2009; 182:6394-6400
30. Lapeyraque AL, Malina M, Fremeaux-Bacchi V, et al: Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med 2011; 364:2561-2563
31. Wong CS, Mooney JC, Brandt JR, et al: Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: A multivariable analysis. Clin Infect Dis 2012; 55:33-41
32. Kimmitt PT, Harwood CR, Barer MR: Toxin gene expression by Shiga toxin-producing Escherichia coli: The role of antibiotics and the bacterial SOS response. Emerging Infect Dis 2000; 6: 458-465
33. Corogeanu D, Willmes R, Wolke M, et al: Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak. BMC Microbiol 2012; 12:160
34. Menne J, Nitschke M, Stingele R, et al: Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ 2012; 345:e4565
35. Kielstein JT, Beutel G, Fleig S, et al: Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxinproducing E. coli O104:H4 induced haemolytic-uraemic syndrome: An analysis of the German STEC-HUS registry. Nephrol Dial Transplant 2012; 27:3807-3815